Issue 34, 2021

Interplay between nanomedicine and protein corona

Abstract

Nanomedicine is recognized as a promising agent for diverse biomedical applications; however, its safety and efficiency in clinical practice remains to be enhanced. A priority issue is the protein corona (PC), which imparts unique biological identities to prototype and determines the actual biological functions in biological fluids. Decades of work has already illuminated abundant considerations that influence the composition of the protein corona. Thereinto, the physical assets of nanomedicines (e.g., size and shape, surface properties, nanomaterials) and the biological environment collectively play fundamental roles in shaping the PC, including the types and quantities of plasma proteins. The properties of nanomedicines are dependent on certain factors. This review aims to explore the applications of nanomedicines by regulating their interplay with PC.

Graphical abstract: Interplay between nanomedicine and protein corona

Article information

Article type
Review Article
Submitted
12 5 2021
Accepted
12 7 2021
First published
12 7 2021

J. Mater. Chem. B, 2021,9, 6713-6727

Interplay between nanomedicine and protein corona

M. Yang, E. Wu, W. Tang, J. Qian and C. Zhan, J. Mater. Chem. B, 2021, 9, 6713 DOI: 10.1039/D1TB01063H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements